IN2014KN02914A - - Google Patents

Info

Publication number
IN2014KN02914A
IN2014KN02914A IN2914KON2014A IN2014KN02914A IN 2014KN02914 A IN2014KN02914 A IN 2014KN02914A IN 2914KON2014 A IN2914KON2014 A IN 2914KON2014A IN 2014KN02914 A IN2014KN02914 A IN 2014KN02914A
Authority
IN
India
Prior art keywords
appendages
epidermis
imbalance
proliferation
differentiation
Prior art date
Application number
Other languages
English (en)
Inventor
Xavier Marat
Benoit Muller
Agnes Thomas-Collignon
Dominique Bernard
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of IN2014KN02914A publication Critical patent/IN2014KN02914A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN2914KON2014 2012-06-06 2013-06-05 IN2014KN02914A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1255267A FR2991578B1 (fr) 2012-06-06 2012-06-06 Composes pour application anti-age et peau seche
PCT/IB2013/054635 WO2013183017A1 (fr) 2012-06-06 2013-06-05 Composés pour la peau sèche et application anti-vieillissement

Publications (1)

Publication Number Publication Date
IN2014KN02914A true IN2014KN02914A (fr) 2015-05-08

Family

ID=47227885

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2914KON2014 IN2014KN02914A (fr) 2012-06-06 2013-06-05

Country Status (9)

Country Link
US (1) US9464080B2 (fr)
EP (1) EP2858624B1 (fr)
JP (1) JP6257603B2 (fr)
CN (1) CN104507455B (fr)
BR (1) BR112014030553B1 (fr)
ES (1) ES2603390T3 (fr)
FR (1) FR2991578B1 (fr)
IN (1) IN2014KN02914A (fr)
WO (1) WO2013183017A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2968201B1 (fr) * 2010-12-07 2017-07-21 Oreal Complexe saspase-flg2, agents modulateurs et utilisations
FR2991578B1 (fr) 2012-06-06 2019-12-27 L'oreal Composes pour application anti-age et peau seche
FR3029413B1 (fr) 2014-12-05 2018-03-09 L'oreal Dispersion aqueuse d'un compose anti-age et composition cosmetique la comprenant
JP7237465B2 (ja) * 2018-05-25 2023-03-13 ポーラ化成工業株式会社 低酸素条件下におけるｏｃｃｌｕｄｉｎ遺伝子、ｃｌａｕｄｉｎ遺伝子及びｚｏ－１遺伝子の発現量を指標とするスクリーニング方法、並びにｃｌａｕｄｉｎ遺伝子の発現低下抑制剤、細胞接着装置の機能低下抑制剤、及び皮膚バリア機能の低下の改善又は予防剤
FR3111807B1 (fr) 2020-06-30 2022-11-25 Oreal Utilisation de composés dérivés pyrido-pyrimidine-triones en tant qu'agents empêchant ou diminuant l'adhésion des micro-organismes sur la peau et/ou les muqueuses
US20220380674A1 (en) * 2021-05-18 2022-12-01 Ticona Llc Photoplethysmographic Sensor Containing A Polymer Composition
CN114397392B (zh) * 2022-01-18 2023-08-11 宁波中盛产品检测有限公司 一种化妆品中玻色因有效物的离子色谱分析方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1060183A (fr) 1951-07-07 1954-03-31 Poutre ou poutrelle posée sur plusieurs appuis, pour toitures, couvertures ou constructions analogues
FR1060179A (fr) 1952-07-05 1954-03-31 Rech S Et D Applic Physicochim Dispositif de support et de fixation d'objets isolés et plus particulièrement de condensateurs électriques ou analogues
JPS59225188A (ja) * 1983-06-02 1984-12-18 Takeda Chem Ind Ltd 縮合ピリミジン誘導体
NZ516873A (en) * 2001-02-12 2003-11-28 Warner Lambert Co Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage
PA8539401A1 (es) * 2001-02-14 2002-10-28 Warner Lambert Co Quinazolinas como inhibidores de mmp-13
EP2266984A1 (fr) * 2009-06-26 2010-12-29 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Pyrido[2,3-d]pyrimidines en tant qu' antagoniste du Wnt pour le traitement du cancer et de l'arthrite
AT511259A3 (de) 2011-02-23 2012-12-15 Pharma Consult Ges M B H & Co Nfg Kg Injektionsspritzenkopf, auspresseinheit sowie daraus gebildete injektionsspritze
FR2991578B1 (fr) 2012-06-06 2019-12-27 L'oreal Composes pour application anti-age et peau seche

Also Published As

Publication number Publication date
BR112014030553B1 (pt) 2020-11-17
ES2603390T3 (es) 2017-02-27
US9464080B2 (en) 2016-10-11
JP6257603B2 (ja) 2018-01-10
JP2015518878A (ja) 2015-07-06
EP2858624B1 (fr) 2016-08-24
CN104507455B (zh) 2020-08-04
EP2858624A1 (fr) 2015-04-15
US20150148356A1 (en) 2015-05-28
WO2013183017A1 (fr) 2013-12-12
FR2991578B1 (fr) 2019-12-27
CN104507455A (zh) 2015-04-08
BR112014030553A2 (pt) 2017-06-27
FR2991578A1 (fr) 2013-12-13

Similar Documents

Publication Publication Date Title
CA2900335C (fr) Analogues synthetiques d'epipolythiodioxopiperazines et leurs utilisations
IN2014KN02914A (fr)
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
IN2014DN07763A (fr)
PH12015501576A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
MX355080B (es) Mejora de la apariencia de la piel con aumento en la intensidad cromatica de la piel.
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
MX342947B (es) Tratamiento de diabetes tipo 2.
IN2014DN06104A (fr)
EA201400748A1 (ru) Композиция для обработки семян
PH12015502405B1 (en) Methods and compositions for wound healing
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
MY179576A (en) Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
HRP20170198T1 (hr) Pripravci koji sadrže kondroitin-sulfat, natokinazu i sulfhidrilne spojeve za upotrebu u liječenju upale
MX2015017095A (es) Composiciones y metodos para tratamiento de la piel.
GB201316955D0 (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
EP2910247A4 (fr) Compositions pour prévenir ou traiter des troubles cutanés allergiques, contenant les agents gpcr19 comme ingrédients actifs
WO2015013709A3 (fr) Méthode de traitement de l'épaississement de la peau
EA201500778A1 (ru) Композиция по уходу за кожей
SG178967A1 (en) Antimicrobial compositions and products
EA201491455A1 (ru) ЭФФЕКТОРЫ β-АРРЕСТИНА, КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ